2018 Speakers

Virginia Acha, Executive Director, Association of the British Pharmaceutical Industry-ABPI

Virginia Acha at World Drug Safety Congress Americas 2018

Anaupam Agarwal, Head, Global Drug Safety and Pharmacovigilance, Zogenix

Anaupam Agarwal at World Drug Safety Congress Americas 2018

Vivek Ahuja, Vice President of Global Pharmacovigilance, Arisglobal Pvt Ltd

Vivek Ahuja at World Drug Safety Congress Americas 2018

Omar Aimer, Pharmacovigilance and drug safety specialist, Rymond Poincaré Hospital - APHP

Omar Aimer at World Drug Safety Congress Americas 2018

Ann Strauss, , Merck

Ann Strauss at World Drug Safety Congress Americas 2018

Rawad Antoun, Manufacturing Site Pharmacovigilance Representative, CSL Behring

Rawad Antoun at World Drug Safety Congress Americas 2018

Felix Arellano, Global Head Pharmacovigilance and Drug Safety, Roche

Felix Arellano at World Drug Safety Congress Americas 2018

Quazi Ataher, Director, Epidemiology, Pfizer

Tony Bahinski, Global Head, Safety Pharmacology, GSK

Tony Bahinski at World Drug Safety Congress Americas 2018

Steven Bailey, Vice President, Worldwide Safety Strategy, Pfizer Pharmaceuticals

Steven Bailey at World Drug Safety Congress Americas 2018

David Balderson, Global Vice President Safety Operations, Sciformix Corp

David Balderson at World Drug Safety Congress Americas 2018

Greg Ball, Principal Statistician, Merck and Co Inc

Greg Ball at World Drug Safety Congress Americas 2018

Khaudeja Bano, Senior Medical Director, Abbott Diagnostics

Khaudeja Bano at World Drug Safety Congress Americas 2018

Fran Bates, Vice President of Technology Services, Sciformix Corp

Fran Bates at World Drug Safety Congress Americas 2018

Anthony Beardsworth, Senior Medical Director - Patient Safety, Eli Lilly

Anthony Beardsworth at World Drug Safety Congress Americas 2018

Arvind Bellur, Director, Head of Safety Data Management, Sanofi

Arvind Bellur at World Drug Safety Congress Americas 2018

Andrea Best, Executive Medical Director, Pharmacovigilance and Patient Safety, AbbVie

Shyam Bhaskaran, Program Officer, Bill and Melinda Gates Foundation

Shyam Bhaskaran at World Drug Safety Congress Americas 2018

Martin Bluth, Chief Medical Officer, Consolidated Laboratory Management Systems

Martin Bluth at World Drug Safety Congress Americas 2018

Mariette Boerstoel, Senior Vice-President, Head Global Drug Safety, Shire Pharmaceuticals

Mariette Boerstoel at World Drug Safety Congress Americas 2018

Kubra Borgardt, Director, AbbVie

Kubra Borgardt at World Drug Safety Congress Americas 2018

Wenda Brennan, Head of PV, PharmaLex GmbH

Wenda Brennan at World Drug Safety Congress Americas 2018

Shelly Brewster, Pharmacovigilance Operations Manager, Intarcia Therapeutics Inc

Shelly Brewster at World Drug Safety Congress Americas 2018

Sarah Buckley, Associate Director, PV Operations, Kite Pharma Inc

Sarah Buckley at World Drug Safety Congress Americas 2018

Niraj Chhaya, Lead Risk Management, Global Pharmacovigilance, Boehringer Ingelheim Pharma GmbH & Co. KG

Niraj Chhaya at World Drug Safety Congress Americas 2018

David Chonzi, VP, Patient Safety and Risk Management, Gilead Sciences

David Chonzi at World Drug Safety Congress Americas 2018

Shaun Comfort, Assoc Director of Risk Management, Genentech A Member of the Roche Group Inc

Shaun Comfort at World Drug Safety Congress Americas 2018

Paul Coplan, Executive Director Risk Management and Epidemiology, Purdue Pharmaceutical Products LP

Barbara Da Silva-Tillmann, Senior Medical Director, Benefit Risk Management, AbbVie

Adrian Dana, Senior Director of Clinical Risk Management and Safety Surveillance, Merck Research Laboratories

Adrian Dana at World Drug Safety Congress Americas 2018

Esther De La Cuesta, A Head, Oncology TKI/ADCs, GPV Benefit Risk Management, Bayer Corp

Esther De La Cuesta at World Drug Safety Congress Americas 2018

Bettina Doepner, Global Regulatory Lead and Development Products, CSL Behring

Bruce Donzanti, Senior Group Director, Regulatory Pharmacovigilance Policy, Genentech

Donna Dougherty, Driector Safety Science, Celgene

Donna Dougherty at World Drug Safety Congress Americas 2018

Debbie Drane, Senior Vice President Global Commercial Development, CSL Behring

Debbie Drane at World Drug Safety Congress Americas 2018

Jay Duhig, Head, Risk Communication and Behavioral Systems, AbbVie

Jay Duhig at World Drug Safety Congress Americas 2018

Susan Duke, MS, MS, Director Benefit Risk Evaluation, US Safety Management, RD Chief Medical Office, GSK

Susan Duke, MS, MS at World Drug Safety Congress Americas 2018

Christine Durkan, Sr. Scientist - CSRM, Merck

Christine Durkan at World Drug Safety Congress Americas 2018

Fatima Yousef, Head Of Quality and Medication Safety unit, King Abdullah International Medical Research Center KAIMRC

Fatima Yousef at World Drug Safety Congress Americas 2018

Bernard Fermini, Chief Scientific Officer, Pfizer

Bernard Fermini at World Drug Safety Congress Americas 2018

Tricia Frantz, Clinical Risk Management Associate Principal Scientist, Drug Safety, Merck

Tricia Frantz at World Drug Safety Congress Americas 2018

Mary Furnari, Clinical Trial Manager, Celgene

Mary Furnari at World Drug Safety Congress Americas 2018

Essam Gehman, Head of Drug Safety and Pharmacovigilance (DSPV), Keyrus Biopharma

Shelly Goodman, Head of Global Pharmacovigilance and Drug Safety, Portola Pharmaceuticals , Inc.

Shelly Goodman at World Drug Safety Congress Americas 2018

Tarek Hammad, Head of Signal Detection and Benefit Risk Assessment, Global Drug Safety Innovation, EMD Serono

Tarek Hammad at World Drug Safety Congress Americas 2018

Michele Hooper, Senior Director Drug Safety, Kite, A Gilead Company

Michele Hooper at World Drug Safety Congress Americas 2018

Eric Hudimac, Associate Director, Intarcia Therapeutics Inc

Eric Hudimac at World Drug Safety Congress Americas 2018

Michael Ibara, Project Leads, UCSF

Michael Ibara at World Drug Safety Congress Americas 2018

Priya Jain, Medical Director, Alkermes

Kala Jayaram, Drug Safety Medical Director, BioMarin Pharmaceutical Inc.

Kala Jayaram at World Drug Safety Congress Americas 2018

Jeremy Jokinen, Senior Director, Safety Decision Analytics, AbbVie

Jeremy Jokinen at World Drug Safety Congress Americas 2018

Jeremy Jokinen, Senior Director, Safety Decision Analytics, AbbVie

Jeremy Jokinen at World Drug Safety Congress Americas 2018

Armughan (Armie) Khan, Associate Director, PV Compliance & Interim Deputy QPPV, Kite, A Gilead Company

Armughan (Armie) Khan at World Drug Safety Congress Americas 2018

Alexandre Kiazand, , AstraZeneca

Kostas Kidos, VP, Head Global Drug Safety Operations, Shire Pharmaceuticals

Kostas Kidos at World Drug Safety Congress Americas 2018

Bill Kivett, Director of Product Management for ProQuest Dialog and Pi2, ProQuest

Bill Kivett at World Drug Safety Congress Americas 2018

Elias Kouchakji, Vice President of Clinical Development, Drug Safety and Pharmacovigilance, Fibro Gen Inc

Elias Kouchakji at World Drug Safety Congress Americas 2018

Christopher Kripas, Vice President, Head of Pharmacovigilance, Genzyme

Christopher Kripas at World Drug Safety Congress Americas 2018

David J Lewis, Global Head of Pharmacovigilance, Novartis

Fabio Lievano, Vice President Safety Sciences, Medical Safety Evaluation, Abbvie Pharmaceuticals Inc

Fabio Lievano at World Drug Safety Congress Americas 2018

Anders Lindholm, Vice President and Head of Drug Safety Therapeutic Area Inflammation and Immunology, Celgene

Mike Liu, Senior Medical Director, Clinical Safety/PV, AbbVie

Mike Liu at World Drug Safety Congress Americas 2018

Peishan Liu-Snyder, Drug Safety Program Manager, Alkermes Inc

Peishan Liu-Snyder at World Drug Safety Congress Americas 2018

Raj Long, Deputy Director, Integrated Development, Global Health, The Bill & Melinda Gates Foundation

Michael Lusiola, Director, Patient Safety, AstraZeneca

Michael Lusiola at World Drug Safety Congress Americas 2018

Antoinette Mangione, Senior Medical Product Expert-Global Medical Affairs, CSL Behring

Antoinette Mangione at World Drug Safety Congress Americas 2018

Barbara Morollo, Head, Pharmacovigilance Operations, Moderna Therapeutics

Barbara Morollo at World Drug Safety Congress Americas 2018

Sarah Mycroft, Director, Clinical Safety Physician, CSL Behring

Sarah Mycroft at World Drug Safety Congress Americas 2018

William O'Brien, Chairman of Medical Surveillance Team and Virology, Global Pharmacovigilance and Epidemiology, Bristol Myers Squibb

William O'Brien at World Drug Safety Congress Americas 2018

Mehul Patel, , Kite, A Gilead Company

Mehul Patel at World Drug Safety Congress Americas 2018

Kirsten H. Paulson, Sr. Director Global CMC-Medical Devices, Pfizer

Kirsten H. Paulson at World Drug Safety Congress Americas 2018

Esther Perez, Associate Director, Clinical Project Management, Eli Lilly and Company

Esther Perez at World Drug Safety Congress Americas 2018

Nidhi Prem, Senior Director / Head of PV Operation, Quark Pharmaceuticals

Nidhi Prem at World Drug Safety Congress Americas 2018

Patrick Puplampu, QP&S Manager, Janssen

Patrick Puplampu at World Drug Safety Congress Americas 2018

Andrew Purchase, Associate Director of Safety & Risk Management, P.R.A. Health Sciences

Sundeep Sethi, Vice President, Safety Operations, AbbVie

Sundeep Sethi at World Drug Safety Congress Americas 2018

Barbara Silva-Tillmann, Senior Medical Director, Benefit Risk Management, AbbVie Ltd

Barbara Silva-Tillmann at World Drug Safety Congress Americas 2018

Laxmi Singh, Drug Safety Professional, Sollers Institute

Laxmi Singh at World Drug Safety Congress Americas 2018

Suzanne Skarzynski, Global Safety Clinical Risk Management Team Leader, Merck And Company

Suzanne Skarzynski at World Drug Safety Congress Americas 2018

Elizabeth Squiers, SVP PV and Clinical Development, Deputy CMO, Quark Pharmaceuticals

Elizabeth Squiers at World Drug Safety Congress Americas 2018

Walter Straus, Associate Vice-President and Therapeutic Area Head, Infectious Diseases, Vaccines, Medical Devices & Combination Products, Merck And Company

Walter Straus at World Drug Safety Congress Americas 2018

Mike Thomas, Medical Director Pharmacovigilance, United Therapeutics

Mike Thomas at World Drug Safety Congress Americas 2018

Ed Tucker, Senior Vice President of Medical Safety, Quality and Compliance, Acerta

Ed Tucker at World Drug Safety Congress Americas 2018

Kevin Tynan, Contract Consultant, GCSP Regions and Pv Operations Global Clinical Safety and Pharmacovigilance, CSL Behring

Veronica Urdaneta, Senior Principal Scientist/ Physician, Merck

Veronica Urdaneta at World Drug Safety Congress Americas 2018

Ale (Maria) Vazquez-Gragg, VP, Head Global Patient Safety, Intarcia Therapeutics Inc

Ale (Maria) Vazquez-Gragg at World Drug Safety Congress Americas 2018

Jose Vega, Chief Safety Officer, Merck & Co., Inc.

Jose Vega at World Drug Safety Congress Americas 2018

Michele Walsh, Manager, Regulatory Affairs, CSL Behring

Michele Walsh at World Drug Safety Congress Americas 2018

William Wan, Head of PV, Taimei

William Wan at World Drug Safety Congress Americas 2018

William Wang, Executive Director, Clinical Safety Statistics, MSD

William Wang at World Drug Safety Congress Americas 2018

Susan Welsh, Chief Safety Officer, CSL Behring

Susan Welsh at World Drug Safety Congress Americas 2018

Kevin Darryl (KD) White, Senior Director, Regional Head (NA) Global Regulatory Affairs, CSL Behring

Kevin Darryl (KD) White at World Drug Safety Congress Americas 2018

Sherry Winter, Product Marketing Manager, Elsevier

Richard Wolf, Head of I.C.S.R. Case Management and Evaluation Regions and Pv Systems, C.S.L. Behring Gmbh

Songlin Xue, Executive Vice President and Global Head of Pharmacovigilance, Astellas

Songlin Xue at World Drug Safety Congress Americas 2018

Elena Yureneva, Principal Scientist, Clinical Safety & Risc Management, MSD

Elena Yureneva at World Drug Safety Congress Americas 2018

Syed Zafeer, Deputy QPPV, Jamjoom Pharmaceuticals

Xiaofeng Zhou, Senior Director, Epidemiology | Worldwide Safety and Regulatory, Pfizer

Xiaofeng Zhou at World Drug Safety Congress Americas 2018